Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Skystar Updates Progress of New Manufacturing Plant

publication date: Sep 8, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Skystar Bio-Pharmaceutical Company, a veterinary medicine company, expects its recently acquired manufacturing facility in Hubei Province to contribute between $4 million and $6 million in revenue per year. The company paid $3.5 million for the facility, including tooling and other startup costs, in a transaction that closed in August. More details....

Stock Symbol: (NSDQ: SKBI)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...